Optimind Pharma Corp. (OMND.CN)

0.0050 0.0000 (0.00%) At close: 01:11PM EDT

Optimind Pharma Corp.

77 King Street West
Suite 3000
Toronto, ON M5K 1G8
Canada
647-891-9379
https://optimindpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. David Goodman	CEO & Director	N/A	N/A	N/A
Mr. Rakesh Malhotra (US), B.Com., C.A., C.P.A., CA (Canada), F.C.A., F	CFO & Secretary	61.27k	N/A	1955

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Optimind Pharma Corp. operates as a pharmaceutical company in Canada. The company offers psychedelic therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It also operates a clinic that provides medical cannabis and other alternative treatments for various medical ailments, which include ketamine-enhanced psychotherapy. The company is headquartered in Toronto, Canada.

Corporate Governance

Optimind Pharma Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.